Covington advised OrbiMed on the deal.OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a molecular…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
